Caspase-2 has been linked to lipoapoptosis, but is apoptosis the sole determinant of increasing the severity of NASH, or can it be anti-inflammatory and linked to other metabolic activity of caspase-2? The gene discussed is CASP2; the disease is metabolic dysfunction-associated steatohepatitis.